Overview

This page describes magnesium supplements: what the mineral does in the body, who is more likely to have low intake, how common forms differ in absorption, and what systematic reviews and guidelines report for each reported use. It keeps topical magnesium separate, notes hospital magnesium sulphate as a different treatment, and sets out harms, interactions and when to ask a clinician.

Where does Magnesium Supplementation come from?

Magnesium as a mineral and nutrient

The National Institutes of Health Office of Dietary Supplements (ODS) describes magnesium as an abundant mineral that is present naturally in many foods, added to other food products, sold as a dietary supplement and found in some medicines such as antacids and laxatives. It acts as a cofactor in more than 300 enzyme systems, and an adult body holds roughly 25 grams, with 50% to 60% in bone.

Magnesium in medicines and supplements

The same fact sheet notes that magnesium is a primary ingredient in some laxatives and in some remedies for heartburn and indigestion, and that supplements are sold in several forms. The sources reviewed for this page do not give a dated history of when magnesium supplements first reached consumers, so no origin date is stated here.

Magnesium sulphate has a separate hospital history. A Cochrane review of anticonvulsants for pre-eclampsia describes it as the drug of choice for treating eclampsia, which is a medical treatment and not a consumer supplement.

What do the names and terms mean?

Names and forms

Supplement labels name the magnesium compound, such as oxide, citrate or chloride. ODS notes that the Supplement Facts panel declares the amount of elemental magnesium, not the weight of the whole compound. Product labels also use other names, including glycinate, malate and threonate. The sources reviewed do not compare those forms, so this page makes no statement about them.

Related terms and distinctions

ODS defines hypomagnesemia as a serum level below 0.75 millimoles per liter and separates symptomatic deficiency, which it calls uncommon in healthy people, from broader inadequacy. Hypermagnesemia means too much magnesium in the blood. Magnesium sulphate given as a drug in obstetric care is a different treatment from oral supplements, and the sources reviewed do not evaluate topical magnesium products such as bath salts, which this page does not cover.

Magnesium Supplementation is one of the products covered by the Machipedia page Dietary Supplements, which this page does not duplicate. Related pages include Nutritional Therapy and Dietetics, which cover food-based approaches, and Myers' Cocktail, a separate page on intravenous mixtures.

What does Magnesium Supplementation involve?

What supplementation involves

In general terms, magnesium supplementation means taking a product that supplies a magnesium compound, either on its own or as part of another preparation, in addition to magnesium from food and drink. ODS states that nutritional needs should be met primarily through the diet, and that supplements may be useful when a nutrient cannot be obtained from food alone. This page gives no amounts and no product advice.

Absorption and form

ODS reports that forms of magnesium that dissolve well in liquid are absorbed more completely, and that small studies found the aspartate, citrate, lactate and chloride forms to be more bioavailable than magnesium oxide and magnesium sulfate. It also reports one study in which very high zinc supplement intakes interfered with magnesium absorption.

Absorption is not the same as clinical effect. ODS attributes the laxative effect of magnesium salts to the osmotic activity of unabsorbed salt in the intestine, which helps explain why a poorly absorbed form such as the oxide is the one a dietetic guideline assesses for constipation. The sources reviewed contain no head-to-head trials showing that one form gives better clinical outcomes than another.

Low intake and who is at risk

ODS lists groups more likely to have inadequate magnesium: people with gastrointestinal diseases that cause chronic diarrhea or malabsorption, people with type 2 diabetes, people with alcohol dependence, and older adults. It reports that symptomatic deficiency from low intake alone is uncommon in otherwise healthy people because the kidneys limit urinary loss, and that some medicines can also lower magnesium levels. ODS also reports that magnesium affects parathyroid hormone and the active form of vitamin D, a link the Machipedia page Vitamin D Supplementation covers from the vitamin side. Whether supplementation is appropriate in these groups is a question for a clinician.

What is Magnesium Supplementation used for?

Uses promoted to consumers

Reviews describe several popular reasons for taking magnesium. A systematic review of anxiety and sleep states that magnesium is popular on social media for anxiety and insomnia, an insomnia review notes it is often purported to improve sleep, and the Cochrane cramp review notes supplements are marketed to prevent muscle cramps. Other studied uses include migraine prevention, constipation, blood pressure, glucose control in type 2 diabetes, depression and muscle soreness after exercise.

Established medical uses of magnesium products

Some magnesium products have medical roles that are separate from supplement use. ODS notes that magnesium is a primary ingredient in some laxatives and antacids. Hospital magnesium sulphate is used for eclampsia and its prevention in pre-eclampsia, and evidence for those uses should not be carried over to oral supplements.

What does the research show?

Muscle cramps and exercise recovery

A 2020 Cochrane review of 11 randomized trials (735 people) found that, for idiopathic cramps in largely older adults, magnesium did not differ meaningfully from placebo: a difference of -0.18 cramps per week (95% CI -0.84 to 0.49; moderate certainty). The authors concluded it is unlikely to provide clinically meaningful prevention for older adults. Evidence for pregnancy-associated cramps was conflicting, from trials at high risk of bias.

A 2024 systematic review of magnesium and exercise-related muscle soreness included only four studies and reported reduced soreness and improved recovery. With so few studies, this is limited evidence.

Migraine prevention

A 2012 American Academy of Neurology and American Headache Society guideline, based on studies published from 1999 to 2009, classed magnesium as probably effective for migraine prevention (Level B). ODS adds that three of four small, short-term placebo-controlled trials found modest reductions in migraine frequency, and that because the typical migraine amount exceeds the upper level for supplements, use should be under a health care provider's direction.

Constipation

A 2025 British Dietetic Association guideline made a strong recommendation for magnesium oxide supplements in chronic constipation, based on a meta-analysis of two trials with 94 people over four weeks. It rated evidence moderate for response to treatment, stool frequency and consistency, and low for some symptoms such as bloating. Gastrointestinal adverse events were reported, and the finding applies to the oxide form in that population.

Sleep, anxiety and depression

A meta-analysis of three trials (151 older adults) found sleep onset 17.36 minutes shorter with oral magnesium than placebo, with no significant change in total sleep time. All trials had moderate-to-high risk of bias and the evidence was low to very low quality, which the authors said is too weak for firm recommendations. A 2024 review of 15 trials found improvements in at least one sleep or anxiety measure in most. Melatonin, another supplement taken for sleep, has its own Machipedia page.

A 2017 review of 18 studies in anxiety-prone groups found mixed positive results and described the evidence quality as poor. A 2023 meta-analysis of seven trials (325 adults with depression) reported lower depression scores, and its authors called for larger high-quality trials.

Blood pressure, diabetes and pregnancy evidence

Blood pressure

A 2025 meta-analysis of 38 trials (2,709 people) reported mean reductions of 2.81 mm Hg systolic and 2.05 mm Hg diastolic versus placebo, larger in people taking blood pressure medicines or with low magnesium, with high heterogeneity. ODS summarizes earlier trials as showing only marginal blood pressure lowering.

Type 2 diabetes

ODS reports that cohort studies link higher magnesium intake with lower type 2 diabetes risk, but cohort data cannot show that supplements cause this. A 2025 meta-analysis of 23 trials (1,345 participants) found lower fasting glucose and a minimal change in glycated hemoglobin. ODS states the American Diabetes Association found insufficient evidence for routine use to improve glycemic control.

Pre-eclampsia

A Cochrane review found magnesium sulphate more than halved the risk of eclampsia in six placebo-controlled trials (11,444 women). That review concerns the drug as an anticonvulsant in pregnancy care. It does not assess oral supplements, and its findings should not be applied to them.

What are the safety considerations?

Gastrointestinal effects and the upper level

ODS reports that high amounts of magnesium from supplements or medicines often cause diarrhea, sometimes with nausea and abdominal cramping, and that carbonate, chloride, gluconate and oxide forms are most often reported. It states the Tolerable Upper Intake Level for supplemental magnesium is 350 mg for adults. In the cramp review, gastrointestinal events occurred in 11% to 37% of people taking magnesium.

Kidney disease and magnesium toxicity

ODS reports that very large amounts, mostly from laxatives and antacids, have caused magnesium toxicity, including fatal hypermagnesemia in a child and an older man, and that the risk increases with impaired kidney function or kidney failure. Signs listed range from low blood pressure, nausea and flushing to breathing difficulty, irregular heartbeat and cardiac arrest.

Medicine interactions

ODS lists interactions with oral bisphosphonates, tetracycline antibiotics and quinolone antibiotics, where magnesium can reduce absorption of the medicine. Loop and thiazide diuretics can increase magnesium loss, potassium-sparing diuretics reduce it, and long-term proton pump inhibitor use can cause low magnesium. ODS advises people taking regular medicines to discuss magnesium intake with their health care providers.

Who should ask a clinician, and product quality

People with kidney disease, those taking the medicines above, and anyone considering magnesium for a symptom such as frequent migraine, persistent cramps, high blood pressure or diabetes should ask a clinician, since supplements should not delay or replace necessary care. ODS notes that independent organizations test supplements and award quality seals, which do not guarantee a product is safe or effective. The sources reviewed do not test magnesium products specifically.

Connected Entries

Showing 8 of 14 related records.

Classification and context

Entry type
Modality
Practice type
Mineral dietary supplementation
Traditions
Not assigned
Concepts
Elemental magnesium, Bioavailability, Hypomagnesemia, Hypermagnesemia, Tolerable upper intake level, Magnesium oxide, Magnesium citrate
Categories
Complementary

MACHIPEDIA AUTHORITY

68/ 100 · Source-Linked Reference

Authority reflects documentation depth, graded source quality, claim coverage, safety completeness, cultural context, and source traceability. It is not a medical recommendation or proof of effectiveness.

Average Source Grade15 / 25
Evidence Coverage10 / 15
Safety Completeness10 / 10
View Authority Breakdown
Average Source Grade15 / 25

Source grades are calculated in this modality's context. Evidence and public-health sources carry more authority weight than directories or consumer pages.

Evidence Coverage10 / 15

A developed Research and Evidence section, 12 evidence-grade sources linked to it; claim-level evidence questions are not assigned yet.

Safety Completeness10 / 10

A Safety and Suitability section is written and safety sources are linked; contraindications and clinical suitability still need formal review.

Cultural Context2 / 10

Tradition and concept links, a linked Tradition page and a historical or cultural source each add to this; community review of living traditions is still needed.

Each source grade is recalculated for this modality from source type, traceability, currency, safety and limitation signals, relevance, coverage, and claim links. Discovery sources additionally use entity, relationship, interaction, evidence, provider, and offering coverage.

Sources and discovery context

Research and public-health sources support evidence and safety context. Directory and discovery sources describe navigation, relationships, practitioners, and access—not clinical efficacy.

Magnesium: Fact Sheet for Health ProfessionalsNIH Office of Dietary Supplements

A government fact sheet summarizing magnesium physiology, intake, uses and risks.

How this source relates
Source link
Exact source page
Relationship
Physiology, deficiency risk groups, forms, upper level, harms, interactions and summaries of uses. Not a systematic review; does not support dosing statements.
Supports sections
History and Origins, Terminology, Practice Description, Claimed Uses, Research and Evidence, Safety and Suitability
Source grade63/100
Dietary Supplements: What You Need To KnowNIH Office of Dietary Supplements

A general consumer fact sheet on supplement labels and quality.

How this source relates
Source link
Exact source page
Relationship
Supports the statement about independent quality seals only. Says nothing specific to magnesium products.
Supports sections
Safety and Suitability
Source grade40/100
Magnesium for skeletal muscle crampsCochrane Database of Systematic Reviews

A Cochrane review of magnesium for skeletal muscle cramps.

How this source relates
Source link
Exact source page
Relationship
11 trials; unlikely to help older adults with cramps; pregnancy-associated cramps conflicting. Not evidence for other uses.
Supports sections
Research and Evidence, Safety and Suitability
Source grade59/100
Magnesium sulphate and other anticonvulsants for women with pre-eclampsiaCochrane Database of Systematic Reviews

A Cochrane review of anticonvulsants for preventing eclampsia.

How this source relates
Source link
Exact source page
Relationship
Concerns magnesium sulphate as an anticonvulsant drug in pregnancy care. Not evidence about oral supplements.
Supports sections
History and Origins, Terminology, Claimed Uses, Research and Evidence
Source grade56/100